Customer Care Tel: 0161 483 5884
Email: ukcustomer@alere.com
Website: www.alere.co.uk
Connecting withBiochemistry
Product Areas
- NHS Health Check
-
- Total Cholesterol
- HbA1C
No products within this category
- Cholesterol plus Glucose
- Triglycerides
- ALT/AST
- hsCRP
- Quality Control
-
- General Chemistry QC
- Therapeutic Drug Monitoring QC
- Immunoassay QC
- Immunololgy QC
- Urine QC
- Miscellaneous
- Drugs of Abuse
- Blood Science QC
-
- Single Markers
- Multimarkers
- Negative / Basematrix
- Biochemistry Reagents
-
- Bile Acids
- Esoteric Assays
- General Chemistry Assays
- Dako Immunology
- Calibrators
- Drugs of Abuse
-
- Rapid Test Panels
- Point of Care Biochemistry
-
- Lipid Screening
- Heart Failure
- Chest Pain
- hsCRP
- AST / ALT
- Anticoagulation Monitoring
- Homocysteine
No products within this category
- HbA1C / Microalbumin
No products within this category
- Blood Gas
- Electrolytes / Hb
- Liver Function Tests
No products within this category
- Chemistry Profiles
- Electrolytes
- Pancreatitis
- POC Biochemistry Instrumentation
- Acute Kidney Injury
- Urinalysis
-
- Urine Test Strips
No products within this category
- Bone Health
-
- Osteoporosis
Member login
Rheumatoid Factor
Quantitative or qualitative methods available for the determination of RF in serum or plasma.
Analyser applications available for quantitative method, on request.
Quality Control materials are available, please refer to our Immunology QC pages
-
NEW Cystatin C Immunoparticles (ERM-DA471/IFCC Standardised)
During the past 10-15 years, Dako has played a key role in introducing Cystatin C to the market and establishing it as a superior marker of kidney function. Read more
- Cardiovascular Medicine |
- Critical Care |
- Diabetes |
- Emergency Medicine |
- General Practice |
- Hospital Pathology |
- NHS Health Checks |
- Sexual Health |
- Telehealth & Telemedicine |
- Women's Health
Site Map | Privacy Policy © Copyright Alere. All Rights Reserved. Web design by iWeb: UK Ecommerce Specialist . Hosting by iWeb: UK Magento Hosting .

